Effect of OC459 on the Response to Rhinovirus Challenge in Asthma

NCT02660489 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Asthma
Rhinovirus
Picornaviridae Infections
Common Cold

Interventions

DRUG: OC459
DRUG: Placebo
OTHER: Rhinovirus

Sponsor

Imperial College London

Collaborators

[object Object]
[object Object]